The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

LidoBel 20 mg/ml solution for injection for horses, dogs, and cats.

Bela-Pharm GmbH & Co. KGVPA10445/004/001

Main Information

Trade NameLidoBel 20 mg/ml solution for injection for horses, dogs, and cats.
Active SubstancesLidocaine hydrochloride
Dosage FormSolution for injection
Licence HolderBela-Pharm GmbH & Co. KG
License Holder AddressLohner Straße 19
D-49377 Vechta
Licence NumberVPA10445/004/001

Group Information

ATC CodeQN01BB02 lidocaine
Therapeutic ClassNeurological Preparations


License statusAuthorised
Licence Issued06/07/2018
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back